This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46378890
rdf:type
wikibase:Item
schema:description
2005年学术文章 مقالهٔ علمی научни чланак سائنسی مضمون vedecký článok artikulong pang-agham tieteellinen artikkeli научни чланак 2005年學術文章 2005年学术文章 teaduslik artikkel 2005년 논문 artículu científicu სამეცნიერო სტატია مقالة علمية научная статья επιστημονικό άρθρο article scientific 2005年學術文章 wissenschaftlicher Artikel mokslinis straipsnis 2005 nî lūn-bûn articolo scientifico мақолаи илмӣ scientific article bài báo khoa học 2005年学术文章 мақолаи илмӣ գիտական հոդված naučni članak article científic vitskapeleg artikkel ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel 2005年學術文章 bilimsel makale מאמר מדעי บทความทางวิทยาศาสตร์ artigo científico (publicado na 2005) artikull shkencor artykuł naukowy 2005年學術文章 научна статия 2005年の論文 artigo científico tudományos cikk 2005年學術文章 vitenskapelig artikkel article scientifique (publié 2005) 2005年學術文章 articol științific 2005年学术文章 vetenskaplig artikel vědecký článek videnskabelig artikel (udgivet 2005) 2005年学术文章 scienca artikolo наукова стаття, опублікована в березні 2005 artículo científico publicado en 2005 artigo científico (publicado na 2005)
p:P577
wds:Q46378890-B73CA6AA-490E-47BA-8489-EC8DCB0955B4
wdt:P577
2005-03-14T00:00:00Z
p:P407
wds:Q46378890-152D6A45-5F13-4A1C-99D1-20CE959BF378
wdt:P407
wd:Q1860
p:P2093
wds:Q46378890-BC0544B9-18DD-4DF2-8EC9-65FC4C66BFD3 wds:Q46378890-B4C861BA-99C0-4162-AC38-E2EFBFEB24F7 wds:Q46378890-9F90DB2F-447D-4FC5-A32E-57A8D70A517B wds:Q46378890-9FF5A9DE-0D87-442C-BD47-C16BBD605707 wds:Q46378890-05BAF554-6B6F-4D2D-9CB8-C9B62894E38C wds:Q46378890-1D624C48-B1DB-4462-81E5-EC86AFB7C346 wds:Q46378890-2691A30F-A426-49EA-A4E5-9C06372EC6EB wds:Q46378890-0DFE5230-FC08-4732-A8A3-69F88E8E630A wds:Q46378890-86B8491A-8AE3-4961-B7A9-9C93F8C70102 wds:Q46378890-6E9194C1-F86A-49B9-A54F-F89ECB2F4C15 wds:Q46378890-781DF6AC-3863-4D3B-AA48-1501AC7797BC wds:Q46378890-581405EA-C049-4C90-94B7-DAF7B6A42910
wdt:P2093
Ian E Smith Margaret Hills Anthony Skene Geraldine Walsh Irene Boeddinghaus Stephen Francis Janine Salter Susan Ashley Simone Detre Steve R Ebbs Clive Griffith J Michael Dixon
rdfs:label
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists
skos:prefLabel
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists
schema:name
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists
p:P50
wds:Q46378890-2F4BD968-CD65-4760-95A9-8A5A43E0D2E5
wdt:P50
wd:Q53099690
p:P1476
wds:Q46378890-8234C4FC-60F4-48BA-9BA5-FA36732C42E5
wdt:P1476
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists
p:P304
wds:Q46378890-61E31677-7F99-4770-8FE0-F968C12E9143
wdt:P304
2477-2492
p:P31
wds:Q46378890-509B2E0A-5464-4085-993B-80A87B70005D
wdt:P31
wd:Q13442814
p:P921
wds:Q46378890-EAD6CF95-69DA-4617-B402-3984B537C853 wds:Q46378890-DC9C527C-9E6A-4948-91F3-3338618F4BA8 wds:Q46378890-88090754-DE9D-423A-AAAF-576504B165F7
wdt:P921
wd:Q419143 wd:Q412178 wd:Q864574
p:P698
wds:Q46378890-BEB475F0-E357-4CB4-BC62-4B72ECD9B975
wdtn:P698
n6:15767642
wdt:P698
15767642
p:P1433
wds:Q46378890-B4FB8DEE-3382-47A3-AC7E-4A2679C2B923
wdt:P1433
wd:Q400292
p:P433
wds:Q46378890-4474726A-032D-4B37-BA60-173CA01C3BD4
p:P478
wds:Q46378890-5250008E-2F99-479C-AE12-65A7BA8BCA9E
wdt:P433
11
wdt:P478
23
p:P356
wds:Q46378890-863914D6-31F9-4BA7-9A12-1A879A5CE2A9
wdtn:P356
n10:JCO.2005.07.559
wdt:P356
10.1200/JCO.2005.07.559